FoundationOne CDx testing accurately determines whole arm 1p19q codeletion status in gliomas.
Radwa SharafDean C PavlickGarrett M FramptonMaureen CooperJacqueline JenkinsNatalie DanzigerJames HaberbergerBrian M AlexanderTimothy CloughesyWilliam H YongLinda M LiauPhioanh L NghiemphuMatthew JiAlbert LaiShakti H RamkissoonLee A AlbackerPublished in: Neuro-oncology advances (2021)
1p19q codeletion status derived from FoundationOne testing is highly concordant with FISH results. Genomic profiling may be a reliable substitute for traditional FISH testing while also providing IDH1/2 status.